Photo from wikipedia
Risk-stratification and treatment intensification according to minimal residual disease (MRD) analysis has improved outcomes of patients with acute lymphoblastic leukemia (ALL).[1][1],[2][2] However, a significant proportion of patients with T-cell ALL… Click to show full abstract
Risk-stratification and treatment intensification according to minimal residual disease (MRD) analysis has improved outcomes of patients with acute lymphoblastic leukemia (ALL).[1][1],[2][2] However, a significant proportion of patients with T-cell ALL (T-ALL) still experience early relapse or
Keywords:
impact absence;
lymphoblastic leukemia;
acute lymphoblastic;
patients cell;
prognostic impact
Journal Title: Haematologica
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Haematologica
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!